Polaris (@polaris_hq) 's Twitter Profile
Polaris

@polaris_hq

ML-ready datasets and benchmarks for drug discovery.
polarishub.io

ID: 1771167738498523136

calendar_today22-03-2024 13:31:20

153 Tweet

578 Takipçi

0 Takip Edilen

Polaris (@polaris_hq) 's Twitter Profile Photo

We’re hosting Peter Škrinjar for a webinar to discuss his latest paper “Have protein co-folding methods moved beyond memorization?” 🚀 Peter will discuss the limitations of current co-folding models, the challenges of memorization in ligand pose prediction, and what is needed

We’re hosting <a href="/peter_skrinjar/">Peter Škrinjar</a> for a webinar to discuss his latest paper “Have protein co-folding methods moved beyond memorization?” 🚀

Peter will discuss the limitations of current co-folding models, the challenges of memorization in ligand pose prediction, and what is needed
Polaris (@polaris_hq) 's Twitter Profile Photo

⚡ The intermediate leaderboard for the Antiviral Challenge is now live! 👀 See how you placed: antiviral.polarishub.io The challenge officially ends on March 10th, but there’s one more chance to see how you stack up before the final results. Submit your predictions by midnight

⚡ The intermediate leaderboard for the Antiviral Challenge is now live!

👀 See how you placed: antiviral.polarishub.io

The challenge officially ends on March 10th, but there’s one more chance to see how you stack up before the final results. Submit your predictions by midnight
Polaris (@polaris_hq) 's Twitter Profile Photo

Polaris is on a mission to bring innovators and practitioners closer together to develop methods that matter. Today, we’re excited to welcome Nicola Richmond (Recursion), Michael Reutlinger (Roche), and Nils Weskamp (Boehringer Ingelheim) to the Small Molecule Steering Committee!

Polaris is on a mission to bring innovators and practitioners closer together to develop methods that matter.

Today, we’re excited to welcome Nicola Richmond (<a href="/RecursionPharma/">Recursion</a>), Michael Reutlinger (<a href="/Roche/">Roche</a>), and Nils Weskamp (<a href="/Boehringer/">Boehringer Ingelheim</a>) to the Small Molecule Steering Committee!
Polaris (@polaris_hq) 's Twitter Profile Photo

Reminder - this webinar is happening today at 11 AM ET! Join us live in ~40 minutes: us06web.zoom.us/webinar/regist…

Polaris (@polaris_hq) 's Twitter Profile Photo

Thanks to everyone who joined us last week! You can now watch the recording of the webinar: youtube.com/watch?v=_ykP_t…

Polaris (@polaris_hq) 's Twitter Profile Photo

Did you miss the cutoff for the last intermediate leaderboard of the antiviral challenge? We’re doing one last leaderboard update before the challenge officially ends on March 10th! Submit something by midnight, Feb 26th to see how you stack up against everyone else. Submit

Did you miss the cutoff for the last intermediate leaderboard of the antiviral challenge?

We’re doing one last leaderboard update before the challenge officially ends on March 10th! Submit something by midnight, Feb 26th to see how you stack up against everyone else.

Submit
Polaris (@polaris_hq) 's Twitter Profile Photo

🚀 Leaderboard Update: Antiviral Challenge! 🚀 The latest rankings are in—check out where you stand: antiviral.polarishub.io Missed this update? No worries, you still have time to compete! The challenge runs until March 10th at midnight, so there’s still a chance to

🚀 Leaderboard Update: Antiviral Challenge! 🚀

The latest rankings are in—check out where you stand: antiviral.polarishub.io

Missed this update? No worries, you still have time to compete! The challenge runs until March 10th at midnight, so there’s still a chance to
Polaris (@polaris_hq) 's Twitter Profile Photo

📢 Antiviral Challenge Deadline Extended! 🦠 Good news! We’ve extended the deadline for the Antiviral Challenge until March 14th at 12:00 PM ET — more time to refine your models, test new approaches, and submit your best results! 💪 💡 To be eligible for the final and official

📢 Antiviral Challenge Deadline Extended! 🦠

Good news! We’ve extended the deadline for the Antiviral Challenge until March 14th at 12:00 PM ET — more time to refine your models, test new approaches, and submit your best results! 💪

💡 To be eligible for the final and official